Repligen Q4 revenue $186.5M (+72% YoY); FY 2022 guidance $800-830M (19-24% growth)

REPLIGEN CORP

2021-FY EPS reported $2.24 revenue$670,534,000

Q4 revenue $186.5M (+72% YoY, organic +69%); GAAP EPS $0.50, adjusted EPS $0.81.
FY 2021 revenue $670.5M (+83% YoY); GAAP EPS $2.24, adjusted EPS $3.06.
FY 2022 revenue guidance $800-830M (19-24% growth); adjusted EPS guidance $3.21-$3.30.
Base business contributed 66% of FY revenue; Filtration segment grew ~130% for the year.
Completed acquisition of BioFlex Solutions; cash $603.8M at year-end.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.